Dr. Hensing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Ridge Ave
Div. Of Hematology-Oncology
Evanston, IL 60201Phone+1 888-909-5222Fax+1 847-570-2336
Education & Training
Northwestern UniversityMS, Healthcare Quality and Patient Safety, 2015 - 2017
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1997 - 1999- University of North Carolina HospitalsResidency, Internal Medicine, 1994 - 1997
University of Maryland School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2003 - 2026
NC State Medical License 1996 - 2003- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 146 citationsMolecular pathways and therapeutic targets in lung cancerEmma Shtivelman, Thomas A. Hensing, George R. Simon, Phillip A. Dennis, Gregory A. Otterson
Oncotarget. 2014-04-08 - 138 citationsPhase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung CancerJyoti D. Patel, Thomas A. Hensing, Alfred Rademaker, Eric M. Hart, Matthew G. Blum
Journal of Clinical Oncology. 2009-07-10 - 19 citationsShould Health-Related Quality of Life Be Measured in Cancer Symptom Management Clinical Trials? Lessons Learned Using the Functional Assessment of Cancer TherapyDavid Cella, Lynne I. Wagner, John Cashy, Thomas A. Hensing, Susan Yount
Journal of the National Cancer Institute. Monographs. 2007-10-01
Press Mentions
Advancing Stage III NSCLC Care Requires Personalized, Multidisciplinary ApproachOctober 5th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
